Differentiate next-generation GLP-1s by quality of weight loss By Shipra Patel, M.D., Therapeutic Area Lead, Endocrinology, Amy Pace, ScD, Vice President, Biostatistics, Nathan Noakes, Sensor Solutions Director The rise of highly effective glucagon-like peptide-1 receptor agonists (GLP-1s) and multi-agonists has transformed obesity research into a multi-billion-dollar industry with strong momentum and fierce competition
At a bare minimum, all authors must be certified nutrition coaches by either the National Academy of Sports Medicine, International Sport Sciences Association, or Precision Nutrition
Store the reconstituted vial refrigerated at **28C, protected from light, and use within 28 days**
Understanding variations and fluctuations in the concentrations of host or microbiota-derived metabolites that can be used to infer processes contributing to the symptoms and severity of IBS will provide important new insights for functional gastrointestinal disorders (FGDs) research
When patients encounter the same allergen again, mast cells and basophils will undergo IgE-mediated activation, which promotes the release of inflammatory mediators, especially histamine and leukotrienes